Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan
· Delayed Price · Currency is TWD 54.50
+2.10 (4.01%)
Feb 17, 2025, 9:00 AM CST
Orient EuroPharma Revenue
Orient EuroPharma had revenue of 1.07B TWD in the quarter ending September 30, 2024, a decrease of -2.54%. This brings the company's revenue in the last twelve months to 4.47B, down -4.12% year-over-year. In the year 2023, Orient EuroPharma had annual revenue of 4.59B, down -2.93%.
Revenue (ttm)
4.47B
Revenue Growth
-4.12%
P/S Ratio
1.06
Revenue / Employee
13.19M
Employees
339
Market Cap
4.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.59B | -138.56M | -2.93% |
| Dec 31, 2022 | 4.73B | -36.57M | -0.77% |
| Dec 31, 2021 | 4.77B | -616.63M | -11.45% |
| Dec 31, 2020 | 5.38B | -709.60M | -11.65% |
| Dec 31, 2019 | 6.09B | 583.08M | 10.58% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 8.32B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 16.71B |
| Lotus Pharmaceutical | 17.59B |
| Lumosa Therapeutics | 37.82M |
| Oneness Biotech | 112.20M |
| Polaris Group | 75.65M |
| Pegavision | 7.06B |